ProofPilot is an American Internet company with offices in New York City. ProofPilot is a Digital Protocol Automation platform that eliminates guesswork and protocol deviations to create high-performance experiences for sites and patients. Chris Venezia joined as the Chief Executive Officer in 2022.[1]
Company type | Clinical trial platform |
---|---|
Industry | |
Headquarters | |
Key people | Chris Venezia |
Products | ProofPilot |
Website | www |
ProofPilot grew out of the consulting firm Cyclogram in 2013. Matthew Amsden, started Cyclogram in 2005.[2]
Early versions of the platform supported studies in the United States, Brazil and Peru.[1] ProofPilot participated in the BluePrint Health Incubator program in the winter of 2014.[3]
Amsden has talked about the challenges of creating a digital health startup and the cultural disconnect between buyers and VC-backed startups. He says that the typical venture-backed startup rulebook almost killed ProofPilot.[4] The company relaunched the product in late 2017 after not taking on customers for nearly 30 months.[5]
The ProofPilot platform is split in three parts. The first gives users the ability to design research studies. The design process (and resulting participant experience) is based on a concept called micro-interactions.[6] Non-experienced study designers can use study templates and fill in the blanks to create a study.[7] The second is the participant experience. Study designers launch the study, it goes through an automatic external regulatory review by Veritas IRB in Montreal, Quebec, Canada.[8] Then participants begin engaging in the study via mobile phones and desktop computers. ProofPilot has publicly stated it has deprioritized development of a native iOS and Android application because Progressive web apps provide a better user experience.[9] The system also provides reporting of findings.
In September 2016, ProofPilot formed a partnership with Veritas IRB in Montreal, Quebec, Canada. Given that many of its customers are not academic institutions and don't have an in-house review process, all studies launched on ProofPilot will be reviewed by Veritas before going live.[10]